Caristo’s novel technology transforms the diagnostic accuracy of routine coronary CT angiograms, a test used to identify patients with suspected heart disease. Using artificial intelligence, our proprietary technology provides unique insights about inflammation in the coronary arteries, the root cause of most heart attacks.
Our Founder and CSO Professor Charalambos Antoniades has generated considerable media interest with his recent simultaneous ESC Congress presentation and European Heart Journal paper. In this work he ...
At the European Society of Cardiology Congress in Paris this week, the research team behind Caristo Diagnostics – led by Professor Charalambos Antoniades – presented a paper in the Young I...
Sep 03 — Our Founder and Chief Scientific Officer Professor Charalambos Antoniades today presented a late-breaking paper at the ESC Congress in Paris, with a simultaneous publication in the Euro...
The validity of our novel biomarker, the Fat Attenuation Index (FAI), has recently been confirmed in a study by Kwiecinski et al, published in the Journal of the American College of Cardiology: Cardio...
American College of Cardiology Conference: At the American College of Cardiology Conference, an exciting abstract from Scientists at the US National Institute of Health (NIH) was presented showing a s...
GDPR Statement.
For the purpose of contacting you, we will save your email address, phone number and the contents of your message. Should you wish to have these records removed please email: dpo@caristo.com
GDPR Statement.
For the purpose of contacting you, we will save your email address, phone number and the contents of your message. Should you wish to have these records removed please email: dpo@caristo.com